SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Oscar Health " 33 found 🔀 AI-powered Shuffle
Oscar Health (OSCR) Shares Moved, What Is Catching Investors' Attention?
Why Oscar Health’s latest product push matters now Fresh commentary around Oscar Health (OSCR) centers on management’s push for higher earnings per share through tighter medical loss ratios, new offerings such as the Lucy Healthcare Marketplace, and wider use of AI tools. At a share price of $29.60, Oscar Health has pulled back over the past week with a 7 day share price return of down 5.4% and a 30 day share price return of down 2.9%. However, the 90 day share price return of 3.8% and year...
Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path
Oscar Health has been on a powerful run in recent years, yet the real question for you today is whether the current share price lines up with what its earnings story can reasonably support. The stock has also seen shorter term pullbacks, which makes the earnings backdrop even more important for anyone trying to judge what they are actually paying for. Over the past 3 years the stock has delivered a very large gain of about 4.3x, which puts a lot of weight on whether the underlying earnings...
Oscar Health: Market Share Gains Are Only Part Of The Plan
Oscar Health (OSCR) buy thesis: $45–$49 fair value on ACA growth, improving margins and Lucie upside.
Oscar Health (OSCR) Stock May Be Undervalued Following Its AI Marketplace Launch
Oscar Health has delivered very strong long term gains for shareholders, yet the recent pullback raises a simple question for anyone looking at the stock today: is the current price still in line with what its earnings can support? Over the past 3 years, Oscar Health has produced a very large share price return, which puts extra focus on whether its earnings can justify that kind of move. Management is talking about higher future earnings per share and better medical loss ratios, which can...
Oscar Health (OSCR) Bets On Lucy As CEO Calls Time On Employer Coverage
Oscar Health (NYSE:OSCR) introduced its AI-driven Lucy Healthcare Marketplace, a digital hub for carriers, brokers, and consumers. The company presented Lucy as part of a shift toward individual coverage options, including support for ICHRA-based benefit designs. Chief executive Mario Schlosser said the traditional employer-sponsored health insurance structure is ending, pointing to alternative coverage models. Oscar Health’s Lucy Healthcare Marketplace launch and public push toward...
Watch CNBC's full interview with Oscar Health CEO Mark Bertolini
Mark Bertolini, Oscar Health CEO, joins 'Power Lunch' to discuss plans to expand its individual and small business coverage to 400-600 new counties by 2029.
Oscar Health CEO Mark Bertolini: We're recreating the ACA model for employers
Mark Bertolini, Oscar Health CEO, joins 'Power Lunch' to discuss plans to expand its individual and small business coverage to 400-600 new counties by 2029.
'The era of employer health insurance is ending': Oscar Health CEO explains
Oscar Health (OSCR) CEO Mark Bertolini sits down with Yahoo Finance Executive Editor Brian Sozzi to discuss the state of the healthcare industry, highlighting why employer-sponsored health insurance might not last forever.
Oscar Health Lowers Medical Cost Outlook. Here's The Caveat.
Oscar Health cut its medical cost outlook, lifting OSCR stock. The insurer's grab for share in a shrinking ACA market looks like a winner — for now.
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market
Oscar Health, Inc. (OSCR) closed at $32.62 in the latest trading session, marking a -3.53% move from the prior day.
Is Oscar Health (OSCR) Outperforming Other Finance Stocks This Year?
Here is how Oscar Health, Inc. (OSCR) and Amerant Bancorp Inc. (AMTB) have performed compared to their sector so far this year.
Oscar Health (OSCR), Why Is This Insurer Drawing Fresh Attention?
Investor rotation into healthcare in response to tougher macro conditions has put Oscar Health (OSCR) on watch, as the insurer rides sector momentum alongside its revenue growth and expanding free cash flow margin. Recent price action backs up that story. Oscar Health’s share price return of 12.46% over the past 90 days and 118.90% year to date, alongside a 1-year total shareholder return of 69.53% and a very large 3-year total shareholder return above 4x, points to momentum that investors...
Should Healthcare Rotation Require Action From Oscar Health Stock Investors?
Morningstar recently reported that tougher macro conditions have pushed investors toward healthcare, with the sector index up about 7% quarter to date and Oscar Health participating in that rotation. Oscar Health, a technology focused insurer with strong revenue and earnings per share growth and a wider free cash flow margin, is drawing interest as investors look for defensively positioned healthcare exposure. We will examine how Oscar Health's investment narrative is shaped by investor...
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader equity markets drove a rotation into healthcare, lifting the sector index by approximately 7% quarter-to-date to reach a 5% valuation premium.
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader equity ma...
Oscar Health, Inc. (OSCR) Just Overtook the 20-Day Moving Average
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Is Oscar Health (OSCR) Fully Priced Following Raised 2026 Guidance?
Oscar Health (OSCR) recently reported record first half 2026 results and raised its full year guidance, a combination that appears to have supported renewed investor attention on the stock this month. At a share price of US$30.47, Oscar Health has seen some short term volatility, with a 7 day share price return down 4.9%. However, the 90 day share price return of 37.07% and 3 year total shareholder return of 363.07% suggest momentum has been strong over a longer stretch as investors react to...
Can Oscar Health (OSCR) Still Look Cheap After Strong Q2?
Oscar Health stock has delivered a very large 3 year return while the broader valuation checks still lean cautious, with a low value score hinting that the recent re rating may not be a simple bargain story. Oscar Health has returned about 3.6x over the past 3 years, which puts a spotlight on whether recent enthusiasm already prices in much of the progress. Recent profitability and revenue growth can support investor expectations for the business, while concerns around medical cost trends...
Oscar Health Q2 Earnings Call Highlights
Oscar Health (NYSE:OSCR) reported record profitability for the first half of 2026 and raised its full-year operating outlook, citing membership growth, disciplined pricing, favorable utilization trends and lower administrative expense ratios. Chief Executive Officer Mark Bertolini said the company
Oscar Health Stock Sinks Amid This Second-Half Risk
OSCR stock dived despite a big earnings beat. Oscar Health management is bullish on the outlook, but big ACA Marketplace coverage shifts limit visibility.
Oscar Health Stock Has Doubled This Year. The ACA Insurer Reports Thursday.
Oscar Health reports second-quarter earnings Thursday morning. The results should show trends in its Affordable Care Act membership.
Has Oscar Health (OSCR) Run Too Far After Its 68% 90 Day Rally?
Oscar Health (OSCR) has been drawing attention after a strong share price run, with investors weighing that performance against mixed valuation signals that suggest the stock is not an obvious bargain. See our latest analysis for Oscar Health. Recent trading has cooled slightly, with the share price down around 3% over the past month and 7 days. That comes after a strong 90 day share price return of about 68% and a very large 3 year total shareholder return, suggesting momentum has been...
Oscar Health's Mark Bertolini on making 'healthcare work for all'
A former CEO of Aetna and Bridgewater (and current chairman of the board of Verizon) brings his leadership philosophy to a challenger brand.
Oscar Health (OSCR) Stock Valuation After Conference Rally And Reaffirmed 2026 Guidance
Oscar Health (OSCR) has been back on investors’ radar after a sharp stock rally following its business update at the Goldman Sachs Healthcare Conference, where management reaffirmed full-year 2026 guidance and highlighted favorable utilization trends. See our latest analysis for Oscar Health. The stock’s rally around the Goldman Sachs Healthcare Conference and upbeat commentary on utilization trends come on top of very strong momentum, with a 90 day share price return of 118.52% and a 1 year...
Why Oscar Health (OSCR) Is Up 10.3% After Leadership Shift And Analyst Upgrade
Oscar Health, Inc. recently amended and restated its employment agreement with co-founder Mario Schlosser as he moved from President of Technology and Chief Technology Officer to Co-Founder & Advisor to the CEO, effective June 1, 2026, while he continues to support the company’s artificial intelligence and digital health agenda and remains on the Board. At the same time, a major Wall Street firm upgraded its view on Oscar Health after Q1 2026 results exceeded expectations and reinforced...
Oscar Health Reports Record Profit As Obamacare Enrollment Jumps
Oscar Health swung to a $679 million first quarter profit – the highest in company history – as its health plan membership jumped more than 50% and medical costs eased.
Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own
Oscar Health launched a new health marketplace to connect consumers to major individual health insurance plans as well as supplemental coverage beyond what it sells.
A Look At Oscar Health (OSCR) Valuation As Positive Commentary And Analyst Optimism Build
What is driving fresh attention on Oscar Health? Oscar Health (OSCR) has moved back into the spotlight after recent comments from Jim Cramer, who highlighted the stock and praised CEO Mark Bertolini, along with increasing analyst optimism ahead of the next earnings report. See our latest analysis for Oscar Health. Recent attention from commentators and rising earnings expectations come after a period of weaker momentum, with a 30 day share price return of 12.8% and year to date share price...
Oscar Health’s CEO Says 2026 Is the Year It Finally Turns a Profit — Here’s What He’s Betting On
Oscar Health (NYSE:OSCR) CEO Mark Bertolini has been making the same promise for four consecutive quarters: 2026 is the year the company turns profitable. Now, with the Q4 2025 results in hand, we can see exactly what he’s betting on to make that happen. The headline numbers from Q4 were rough. EPS came in at ... Oscar Health’s CEO Says 2026 Is the Year It Finally Turns a Profit — Here’s What He’s Betting On
Did Oscar’s Reaffirmed 2026 Outlook and Reinsurance Strategy Just Shift Oscar Health's (OSCR) Investment Narrative?
Oscar Health recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, where management reaffirmed its 2026 financial outlook, addressed concerns about the expiration of ACA subsidies, and discussed open enrollment outcomes. A key insight from the presentation was Oscar’s emphasis on its reinsurance capital strategy, with partners covering 55% of required capital, which management highlighted as a way to support stability while the company manages...
Oscar Health Q4 Earnings Call Highlights
Oscar Health (NYSE:OSCR) outlined a sharp pivot from a difficult 2025 to what management described as a return to profitability in 2026, driven by membership growth, rate actions, and continued administrative cost leverage supported by technology and AI. 2025 results: revenue growth offset by risk
Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025
NEW YORK, February 10, 2026--Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025
Oscar Health, Inc. (OSCR): A Bull Case Theory
We came across a bullish thesis on Oscar Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on OSCR. Oscar Health, Inc.’s share was trading at $17.97 as of November 28th. Oscar Health, Inc. operates as a healthcare technology company in the United States. OSCR is positioned to benefit […]